Predictors of response to anamorelin in gastrointestinal cancer patients with cachexia: a retrospective study

被引：0
|
作者：
Naoto Iwai
Hiroaki Sakai
Kohei Oka
Junichi Sakagami
Takashi Okuda
Chie Hattori
Masashi Taniguchi
Tasuku Hara
Toshifumi Tsuji
Toshiyuki Komaki
Keizo Kagawa
Toshifumi Doi
Takeshi Ishikawa
Hiroaki Yasuda
Yoshito Itoh
机构：
[1] Fukuchiyama City Hospital,Department of Gastroenterology and Hepatology
[2] Kyoto Prefectural University of Medicine,Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science
来源：
Supportive Care in Cancer | 2023年 / 31卷
关键词：
Anamorelin; Lean body mass; Gastrointestinal cancer; Response; Clinical settings;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Predictors of response to anamorelin in gastrointestinal cancer patients with cachexia: a retrospective study
    Iwai, Naoto
    Sakai, Hiroaki
    Oka, Kohei
    Sakagami, Junichi
    Okuda, Takashi
    Hattori, Chie
    Taniguchi, Masashi
    Hara, Tasuku
    Tsuji, Toshifumi
    Komaki, Toshiyuki
    Kagawa, Keizo
    Doi, Toshifumi
    Ishikawa, Takeshi
    Yasuda, Hiroaki
    Itoh, Yoshito
    SUPPORTIVE CARE IN CANCER, 2023, 31 (02)
  • [2] Efficacy and safety of anamorelin for cachexia in patients with gastrointestinal cancer: a retrospective case series
    Shinohara, Yudai
    Kitazono, Takafumi
    Koike, Tomomi
    Shimokawa, Hozumi
    ANNALS OF ONCOLOGY, 2022, 33 : S532 - S532
  • [3] Predictors of efficacy of anamorelin in patients with non-small cell lung cancer and cachexia: A retrospective study
    Ishioka, Yoshiko
    Tanaka, Hisashi
    Makiguchi, Tomonori
    Fujishima, Syunsuke
    Nunomura, Yasuhito
    Sakamoto, Hiroaki
    Shiratori, Toshihiro
    Taima, Kageaki
    Tasaka, Sadatomo
    ONCOLOGY LETTERS, 2024, 27 (01)
  • [4] Early administration of anamorelin improves cancer cachexia in gastrointestinal cancer patients: an observational study
    Matsumoto, Toshihiko
    Cho, Sien
    Nakasya, Akio
    Nagai, Hiroki
    Satake, Hironaga
    Yasui, Hisateru
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [5] The clinical outcomes for anamorelin in advanced gastrointestinal cancer patients with cancer cachexia
    Nishimura, Ari
    Hamauchi, Satoru
    Notsu, Akifumi
    Kawaguchi, Daiki
    Tsugaru, Kai
    Fushiki, Kunihiro
    Oshima, Kotoe
    Tsushima, Takahiro
    Kawakami, Takeshi
    Todaka, Akiko
    Yokota, Tomoya
    Yasui, Hirofumi
    Onozawa, Yusuke
    Yamazaki, Kentaro
    ANNALS OF ONCOLOGY, 2023, 34 : S1439 - S1439
  • [6] Retrospective study of anamorelin therapy for unresectable or recurrent pancreatic cancer with cancer cachexia
    Okada, M. O.
    Ohba, A.
    Mitsunaga, S.
    Shibuki, T.
    Satake, T.
    Watanabe, K.
    Sasaki, M.
    Imaoka, H.
    Maruki, Y.
    Nagashio, Y.
    Kondo, S.
    Susumu, H.
    Morizane, C.
    Ueno, H.
    Ikeda, M.
    Okusaka, T.
    ANNALS OF ONCOLOGY, 2023, 34 : S1638 - S1638
  • [7] Real-world data of anamorelin in advanced gastrointestinal cancer patients with cancer cachexia
    Nishimura, Ari
    Hamauchi, Satoshi
    Notsu, Akifumi
    Fushiki, Kunihiro
    Oshima, Kotoe
    Tsushima, Takahiro
    Kawakami, Takeshi
    Todaka, Akiko
    Yokota, Tomoya
    Yasui, Hirofumi
    Onozawa, Yusuke
    Yamazaki, Kentaro
    BMC PALLIATIVE CARE, 2024, 23 (01):
  • [8] Anamorelin for cancer cachexia
    Nishie, Kenichi
    Sato, Seiichi
    Hanaoka, Masayuki
    DRUGS OF TODAY, 2022, 58 (03) : 97 - 104
  • [9] Anamorelin in Japanese patients with cancer cachexia: an update
    Wakabayashi, Hidetaka
    Arai, Hidenori
    Inui, Akio
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2023, 17 (03) : 162 - 167
  • [10] Responder analysis of anamorelin in patients with cancer cachexia
    Naito, Tateaki
    Sobue, Kanako
    Takiguchi, Toru
    Komura, Naoyuki
    Koichi, Takayama
    ANNALS OF ONCOLOGY, 2022, 33 : S477 - S477
12345